Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Andreeff

Showing results (201-210 of 315) with videos related to

Pageof 32
Sort By:
Transplantation|January 28, 1999
Effective depletion of alloreactive lymphocytes from peripheral blood mononuclear cell preparationsL Garderet, V Snell, D Przepiorka, et al.
Leukemia|August 1, 2008
HOX expression patterns identify a common signature for favorable AMLM Andreeff, V Ruvolo, S Gadgil, et al.
Leukemia|November 25, 2003
Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemiasS Zhao, M Konopleva, M Cabreira-Hansen, et al.
Leukemia|September 1, 1995
A 3-day schedule of fludarabine in previously treated chronic lymphocytic leukemiaL E Robertson, S O'Brien, H Kantarjian, et al.
Current Pharmaceutical Design|August 17, 2005
Beyond single pathway inhibition: MEK inhibitors as a platform for the development of pharmacological combinations with synergistic anti-leukemic effectsM Milella, C M Precupanu, C Gregorj, et al.
Leukemia|July 8, 2005
Quantitative single cell determination of ERK phosphorylation and regulation in relapsed and refractory primary acute myeloid leukemiaM R Ricciardi, T McQueen, D Chism, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1996
Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agentsW Zhang, M A Piatyszek, T Kobayashi, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|March 5, 1998
Rescue from apoptosis in early (CD34-selected) versus late (non-CD34-selected) human hematopoietic cells by very late antigen 4- and vascular cell adhesion molecule (VCAM) 1-dependent adhesion to bone marrow stromal cellsM W Wang, U Consoli, C M Lane, et al.
Leukemia|April 24, 1999
Quantitation of minimal residual disease in acute myelogenous leukemia and myelodysplastic syndromes in complete remission by molecular cytogenetics of progenitor cellsH Engel, J Drach, A Keyhani, et al.
Leukemia & Lymphoma|January 1, 1993
Treatment of myelodysplastic syndromes with AML-type chemotherapyE Estey, S Pierce, H Kantarjian, et al.
Pageof 32

Showing results (201-210 of 315) with videos related to

Sort By:
Pageof 32
Transplantation|January 28, 1999
Effective depletion of alloreactive lymphocytes from peripheral blood mononuclear cell preparationsL Garderet, V Snell, D Przepiorka, et al.
Leukemia|August 1, 2008
HOX expression patterns identify a common signature for favorable AMLM Andreeff, V Ruvolo, S Gadgil, et al.
Leukemia|November 25, 2003
Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemiasS Zhao, M Konopleva, M Cabreira-Hansen, et al.
Leukemia|September 1, 1995
A 3-day schedule of fludarabine in previously treated chronic lymphocytic leukemiaL E Robertson, S O'Brien, H Kantarjian, et al.
Current Pharmaceutical Design|August 17, 2005
Beyond single pathway inhibition: MEK inhibitors as a platform for the development of pharmacological combinations with synergistic anti-leukemic effectsM Milella, C M Precupanu, C Gregorj, et al.
Leukemia|July 8, 2005
Quantitative single cell determination of ERK phosphorylation and regulation in relapsed and refractory primary acute myeloid leukemiaM R Ricciardi, T McQueen, D Chism, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1996
Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agentsW Zhang, M A Piatyszek, T Kobayashi, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|March 5, 1998
Rescue from apoptosis in early (CD34-selected) versus late (non-CD34-selected) human hematopoietic cells by very late antigen 4- and vascular cell adhesion molecule (VCAM) 1-dependent adhesion to bone marrow stromal cellsM W Wang, U Consoli, C M Lane, et al.
Leukemia|April 24, 1999
Quantitation of minimal residual disease in acute myelogenous leukemia and myelodysplastic syndromes in complete remission by molecular cytogenetics of progenitor cellsH Engel, J Drach, A Keyhani, et al.
Leukemia & Lymphoma|January 1, 1993
Treatment of myelodysplastic syndromes with AML-type chemotherapyE Estey, S Pierce, H Kantarjian, et al.
Pageof 32